日本口腔外科学会雑誌
Online ISSN : 2186-1579
Print ISSN : 0021-5163
ISSN-L : 0021-5163
OK-432によりヒト末梢血単核球に誘導される腫瘍細胞傷害活性に関する研究
久保田 英朗今村 英夫片野 光男黒河 博之田中 絹子胡 兆良香月 武
著者情報
ジャーナル フリー

1992 年 38 巻 12 号 p. 1815-1822

詳細
抄録

Antitumor activities of OK-432-stimulated peripheral blood mononuclear cells (PBMC) were examined. Killer activity against natural killer (NK) cell-sensitive K562 as well as lymphokine activated killer (LAK) cell-sensitive Daudi and PC3 target cells were detected among PBMC cultured with a low dose (0.0125-0.05 KE/ml) of OK-432. Kinetic analysis of killer activity showed that it reached a plateau level by 48 h of culture. Various freshly isolated tumor cells from oral cancer patients were also lysed by both the autologous and allogeneic OK-432-stimulated PBMC (OK-MC), suggesting that the specificity of the killer was not restricted by HLA and was thus non-specific. Fluorescence activated cell sortor (FACS) analyses showed that CD57+/CD25+ and CD16+/CD25+ cells were increased in PBMC after 48-h stimulation with OK-432. The killer activity was further augmented by the addition of rIL-2 at the time of killer assay.
Tumor growth inhibitory factor (TGIF) activity, which we previously reported, was found in the culture supernatant (CSN) of OK-MC from various cancer patients. The titer of TGIF from these patients was high enough, 16-64 × of the reciprocal dilution of the CSN, which was almost equivalent to the activity from normal healthy controls.
These results suggest that two kinds of antitumor activities were induced in the OK-432-stimulated PBMC in vitro, the one being cell-mediated and the other lymphokine-mediated (TGIF). OK-MC is thus supposed to be effective for adoptive immunotherapy (AIT) in oral cancer patients.

著者関連情報
© 社団法人日本口腔外科学会
前の記事 次の記事
feedback
Top